Clopidogrel gets green light from NICE for wider use

NICE has recommended wider use of clopidogrel and dipyridamole for preventing occlusive vascular events.

In guidance now out for consultation, clopidogrel can be offered to patients who have had ischaemic stroke, peripheral arterial disease (PAD) or multivascular disease. But it is only recommended for MI if aspirin is unsuitable.

Modified-release dipyridamole plus aspirin may be considered for patients who have had a TIA, NICE advises in the proposals.

For stroke patients, this combination should be recommended only when clopidogrel is not tolerated or contraindicated. It should be offered alone only when treatment with clopidogrel and aspirin are unsuitable in this patient group.

Professor Peter Littlejohns, clinical and public health director at NICE, said the institute could recommend the drug because the price had fallen since it became available as a generic.

He said the draft guidance ‘had the potential to have a significant impact on the treatment of many thousands of patients in England and Wales’.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP time per patient slumps to lowest level in half a decade

GP time per patient slumps to lowest level in half a decade

GP time available per patient has dropped by six and a half minutes since 2015 -...

An uncompromising defender of the NHS: colleagues remember Dr Ron Singer

An uncompromising defender of the NHS: colleagues remember Dr Ron Singer

Colleagues and friends have paid tribute after the death of East London GP Dr Ron...

COVID-19 death rate highest among BAME groups, delayed PHE review confirms

COVID-19 death rate highest among BAME groups, delayed PHE review confirms

Death rates from COVID-19 are highest among patients from BAME groups, according...

GPs face hundreds of complaints over shielding and PPE during pandemic

GPs face hundreds of complaints over shielding and PPE during pandemic

GP practices have faced hundreds of complaints over issues including shielding and...

More than 3,600 GP partners lost in four years as decline accelerates

More than 3,600 GP partners lost in four years as decline accelerates

The number of full-time equivalent (FTE) GP partners in England fell by 3,636 between...

COVID-19 pandemic leaves 2.4m patients stuck in cancer care backlog

COVID-19 pandemic leaves 2.4m patients stuck in cancer care backlog

Around 2.4m patients are waiting longer for cancer tests or treatment because of...